Trough Concentrations of Vancomycin Adult Therapeutic Targets Are Not Appropriate for Children

被引：34
|
作者：
Gordon, Claire L. [1 ]
Thompson, Chantelle [2 ]
Carapetis, Jonathan R. [1 ,3 ,4 ,5 ]
Turnidge, John [6 ,7 ]
Kilburn, Charles [4 ,5 ]
Currie, Bart J. [1 ]
机构：
[1] Royal Darwin Hosp, Dept Infect Dis, Tiwi, NT 0810, Australia
[2] Royal Darwin Hosp, Dept Pharm, Tiwi, NT 0810, Australia
[3] Royal Darwin Hosp, Dept Paediat, Darwin, NT, Australia
[4] Telethon Inst Child Hlth Res, Perth, WA, Australia
[5] Univ Western Australia, Perth, WA 6009, Australia
[6] Womens & Childrens Hosp, SA Pathol, Adelaide, SA, Australia
[7] Univ Adelaide, Adelaide, SA, Australia
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2012年 / 31卷 / 12期
关键词：
vancomycin; Staphylococcus aureus; therapeutic drug monitoring; RESISTANT STAPHYLOCOCCUS-AUREUS; BACTEREMIA; OUTCOMES; INFECTIONS;
D O I：
10.1097/INF.0b013e31826a3eaf
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Despite the need for effective vancomycin therapy, there are few data guiding vancomycin monitoring in children. We reviewed retrospectively vancomycin use in children 1 month to 12 years of age. Initial and adjusted target trough vancomycin concentrations in serum were infrequently achieved regardless of the dosing schedule. Currently recommended trough concentrations need to be re-examined with a more detailed pharmacokinetic study in children.
引用
收藏
页码：1269 / 1271
页数：3
相关论文
共 50 条
  • [1] A Strategy for Dosing Vancomycin to Therapeutic Targets Using Only Trough Concentrations
    John P. Prybylski
    [J]. Clinical Pharmacokinetics, 2017, 56 : 263 - 272
  • [2] A Strategy for Dosing Vancomycin to Therapeutic Targets Using Only Trough Concentrations
    Prybylski, John P.
    [J]. CLINICAL PHARMACOKINETICS, 2017, 56 (03) : 263 - 272
  • [3] Is a standard vancomycin dosing protocol appropriate to achieve therapeutic trough levels in adult neutropenic patients?
    Donovan, Kellye A.
    Sklenicka, Julie
    [J]. PHARMACOTHERAPY, 2012, 32 (10): : E237 - E238
  • [4] Reappraisal of therapeutic vancomycin trough concentrations with empirical dosing in neonatal infections
    Lee, Tzung-Yi
    Hung, Yi-Li
    Shen, Chung -Min
    Kao, Chi-Lan
    Hsieh, Wu-Shiun
    [J]. PEDIATRICS AND NEONATOLOGY, 2023, 64 (02): : 176 - 182
  • [5] Evaluation of concurrent vancomycin and pentobarbital use and the achievement of therapeutic vancomycin trough concentrations in a Neurosciences Intensive Care Unit
    Smidt, Danielle N.
    Erin, Melissa C.
    Kiser, Tyree H.
    [J]. PHARMACOTHERAPY, 2012, 32 (10): : E284 - E284
  • [6] Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children
    Peng, Lengyue
    Gao, Yawen
    Zhang, Guangli
    Tian, Xiaoyin
    Xu, Huiting
    Yu, Qinghong
    Cheng, Jie
    Li, Yuanyuan
    Li, Qinyuan
    Chen, Yingfu
    Zhao, Wei
    Luo, Zhengxiu
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [7] Vancomycin Therapeutic Targets and Nephrotoxicity in Critically Ill Children With Cancer
    Seixas, Glaucia T. F.
    Araujo, Orlei R.
    Silva, Dafne C. B.
    Arduini, Rodrigo G.
    Petrilli, Antonio S.
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (02) : E56 - E62
  • [8] Variability in Trough Total and Unbound Teicoplanin Concentrations and Achievement of Therapeutic Drug Monitoring Targets in Adult Patients with Hematological Malignancy
    Byrne, Catherine J.
    Roberts, Jason A.
    McWhinney, Brett
    Fennell, Jerome P.
    O'Byrne, Philomena
    Deasy, Evelyn
    Egan, Sean
    Desmond, Ronan
    Enright, Helen
    Ryder, Sheila A.
    D'Arcy, Deirdre M.
    McHugh, Johnny
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
  • [9] Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
    Neely, Michael N.
    Youn, Gilmer
    Jones, Brenda
    Jelliffe, Roger W.
    Drusano, George L.
    Rodvold, Keith A.
    Lodise, Thomas P.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (01) : 309 - 316
  • [10] Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin
    Whitney R. Buckel
    Shahira Ghobrial
    Pranita D. Tamma
    Aaron M. Milstone
    Yuan Zhao
    Alice J. Hsu
    [J]. Pediatric Drugs, 2017, 19 : 43 - 51
12345